How can inflammatory biomarkers be used as a screening tool for neuropathy in patients with type 2 diabetes mellitus?
Abstract
Inflammatory biomarkers show potential for use in screening diabetic neuropathy in T2DM, but current evidence indicates limited diagnostic accuracy. Further research is required to establish their effectiveness in clinical practice.
Fields of Study & Subjects
Pain Mechanisms and Treatments
Peripheral Neuropathies and Disorders
Diabetic Foot Ulcer Assessment and Management
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 15 February 2026
- Language
- EN